SARTORIUS STEDIM BIOTECH (56S1.DE) Stock Fundamental Analysis
FRA:56S1 - Deutsche Boerse Ag - FR0013154002 - Common Stock - Currency: EUR
56S1 gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 16 industry peers in the Life Sciences Tools & Services industry. Both the profitability and the financial health of 56S1 get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, 56S1 is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
56S1 had positive earnings in the past year.
In the past year 56S1 had a positive cash flow from operations.
Each year in the past 5 years 56S1 has been profitable.
In the past 5 years 56S1 always reported a positive cash flow from operatings.
1.2 Ratios
56S1 has a Return On Assets of 2.46%. This is comparable to the rest of the industry: 56S1 outperforms 56.25% of its industry peers.
56S1's Return On Equity of 5.14% is in line compared to the rest of the industry. 56S1 outperforms 50.00% of its industry peers.
56S1 has a worse Return On Invested Capital (4.36%) than 62.50% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 56S1 is above the industry average of 6.90%.
The 3 year average ROIC (10.41%) for 56S1 is well above the current ROIC(4.36%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.46% | ||
| ROE | 5.14% | ||
| ROIC | 4.36% |
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
1.3 Margins
56S1 has a Profit Margin of 7.15%. This is in the better half of the industry: 56S1 outperforms 75.00% of its industry peers.
56S1's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 14.05%, 56S1 perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
56S1's Operating Margin has declined in the last couple of years.
The Gross Margin of 56S1 (43.89%) is better than 68.75% of its industry peers.
56S1's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.05% | ||
| PM (TTM) | 7.15% | ||
| GM | 43.89% |
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
2. Health
2.1 Basic Checks
56S1 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, 56S1 has more shares outstanding
Compared to 5 years ago, 56S1 has more shares outstanding
56S1 has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.14 indicates that 56S1 is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 4.14, 56S1 belongs to the best of the industry, outperforming 81.25% of the companies in the same industry.
56S1 has a debt to FCF ratio of 5.03. This is a neutral value as 56S1 would need 5.03 years to pay back of all of its debts.
With a Debt to FCF ratio value of 5.03, 56S1 perfoms like the industry average, outperforming 56.25% of the companies in the same industry.
56S1 has a Debt/Equity ratio of 0.72. This is a neutral value indicating 56S1 is somewhat dependend on debt financing.
The Debt to Equity ratio of 56S1 (0.72) is worse than 68.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | 5.03 | ||
| Altman-Z | 4.14 |
ROIC/WACC0.52
WACC8.36%
2.3 Liquidity
56S1 has a Current Ratio of 1.85. This is a normal value and indicates that 56S1 is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of 56S1 (1.85) is better than 87.50% of its industry peers.
56S1 has a Quick Ratio of 1.14. This is a normal value and indicates that 56S1 is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.14, 56S1 is in the better half of the industry, outperforming 68.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.85 | ||
| Quick Ratio | 1.14 |
3. Growth
3.1 Past
56S1 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.97%.
The Earnings Per Share has been growing slightly by 4.19% on average over the past years.
Looking at the last year, 56S1 shows a small growth in Revenue. The Revenue has grown by 5.21% in the last year.
The Revenue has been growing by 14.05% on average over the past years. This is quite good.
EPS 1Y (TTM)4.97%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%34.88%
Revenue 1Y (TTM)5.21%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%11.65%
3.2 Future
Based on estimates for the next years, 56S1 will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.34% on average per year.
56S1 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.61% yearly.
EPS Next Y23.98%
EPS Next 2Y25.51%
EPS Next 3Y24.81%
EPS Next 5Y19.34%
Revenue Next Year8.6%
Revenue Next 2Y9.87%
Revenue Next 3Y10.54%
Revenue Next 5Y9.61%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 55.66, the valuation of 56S1 can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of 56S1 indicates a slightly more expensive valuation: 56S1 is more expensive than 75.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of 56S1 to the average of the S&P500 Index (28.18), we can say 56S1 is valued expensively.
Based on the Price/Forward Earnings ratio of 38.36, the valuation of 56S1 can be described as expensive.
75.00% of the companies in the same industry are cheaper than 56S1, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 20.81. 56S1 is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 55.66 | ||
| Fwd PE | 38.36 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 56S1 is valued a bit more expensive than 75.00% of the companies in the same industry.
62.50% of the companies in the same industry are cheaper than 56S1, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 35.27 | ||
| EV/EBITDA | 32.06 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 56S1 does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as 56S1's earnings are expected to grow with 24.81% in the coming years.
PEG (NY)2.32
PEG (5Y)13.27
EPS Next 2Y25.51%
EPS Next 3Y24.81%
5. Dividend
5.1 Amount
56S1 has a yearly dividend return of 0.33%, which is pretty low.
56S1's Dividend Yield is slightly below the industry average, which is at 0.82.
With a Dividend Yield of 0.33, 56S1 pays less dividend than the S&P500 average, which is at 2.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.33% |
5.2 History
The dividend of 56S1 has a limited annual growth rate of 4.44%.
Dividend Growth(5Y)4.44%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
32.84% of the earnings are spent on dividend by 56S1. This is a low number and sustainable payout ratio.
The dividend of 56S1 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP32.84%
EPS Next 2Y25.51%
EPS Next 3Y24.81%
FRA:56S1 (5/2/2025, 7:00:00 PM)
211.5
+11.4 (+5.7%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners11.63%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap20.59B
Analysts78.89
Price Target243.82 (15.28%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.33% |
Yearly Dividend0.71
Dividend Growth(5Y)4.44%
DP32.84%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.91%
Min EPS beat(2)7.63%
Max EPS beat(2)22.18%
EPS beat(4)2
Avg EPS beat(4)0.98%
Min EPS beat(4)-20.27%
Max EPS beat(4)22.18%
EPS beat(8)2
Avg EPS beat(8)-16.9%
EPS beat(12)2
Avg EPS beat(12)-16.88%
EPS beat(16)5
Avg EPS beat(16)-11.85%
Revenue beat(2)2
Avg Revenue beat(2)3.21%
Min Revenue beat(2)2.91%
Max Revenue beat(2)3.52%
Revenue beat(4)3
Avg Revenue beat(4)0.7%
Min Revenue beat(4)-5.11%
Max Revenue beat(4)3.52%
Revenue beat(8)4
Avg Revenue beat(8)-1.35%
Revenue beat(12)4
Avg Revenue beat(12)-1.7%
Revenue beat(16)8
Avg Revenue beat(16)12.23%
PT rev (1m)-5.26%
PT rev (3m)8.43%
EPS NQ rev (1m)-1.38%
EPS NQ rev (3m)0.4%
EPS NY rev (1m)-0.49%
EPS NY rev (3m)1.23%
Revenue NQ rev (1m)-3.7%
Revenue NQ rev (3m)-1.81%
Revenue NY rev (1m)-0.95%
Revenue NY rev (3m)0.2%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 55.66 | ||
| Fwd PE | 38.36 | ||
| P/S | 7.2 | ||
| P/FCF | 35.27 | ||
| P/OCF | 23.41 | ||
| P/B | 5.18 | ||
| P/tB | N/A | ||
| EV/EBITDA | 32.06 |
EPS(TTM)3.8
EY1.8%
EPS(NY)5.51
Fwd EY2.61%
FCF(TTM)6
FCFY2.84%
OCF(TTM)9.04
OCFY4.27%
SpS29.36
BVpS40.81
TBVpS-5.43
PEG (NY)2.32
PEG (5Y)13.27
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.46% | ||
| ROE | 5.14% | ||
| ROCE | 5.47% | ||
| ROIC | 4.36% | ||
| ROICexc | 4.84% | ||
| ROICexgc | 15.14% | ||
| OM | 14.05% | ||
| PM (TTM) | 7.15% | ||
| GM | 43.89% | ||
| FCFM | 20.42% |
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
ROICexc(3y)10.84%
ROICexc(5y)15.37%
ROICexgc(3y)26.31%
ROICexgc(5y)36.49%
ROCE(3y)13.07%
ROCE(5y)18.3%
ROICexcg growth 3Y-36.77%
ROICexcg growth 5Y-16.49%
ROICexc growth 3Y-43.34%
ROICexc growth 5Y-25.09%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
F-Score7
Asset Turnover0.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | 5.03 | ||
| Debt/EBITDA | 4 | ||
| Cap/Depr | 95.85% | ||
| Cap/Sales | 10.35% | ||
| Interest Coverage | 2.25 | ||
| Cash Conversion | 123.84% | ||
| Profit Quality | 285.66% | ||
| Current Ratio | 1.85 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | 4.14 |
F-Score7
WACC8.36%
ROIC/WACC0.52
Cap/Depr(3y)182.98%
Cap/Depr(5y)186.68%
Cap/Sales(3y)13.87%
Cap/Sales(5y)12.23%
Profit Quality(3y)126.76%
Profit Quality(5y)109.63%
High Growth Momentum
Growth
EPS 1Y (TTM)4.97%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%34.88%
EPS Next Y23.98%
EPS Next 2Y25.51%
EPS Next 3Y24.81%
EPS Next 5Y19.34%
Revenue 1Y (TTM)5.21%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%11.65%
Revenue Next Year8.6%
Revenue Next 2Y9.87%
Revenue Next 3Y10.54%
Revenue Next 5Y9.61%
EBIT growth 1Y-0.84%
EBIT growth 3Y-23.35%
EBIT growth 5Y2.67%
EBIT Next Year85.65%
EBIT Next 3Y36.02%
EBIT Next 5Y24.38%
FCF growth 1Y325.99%
FCF growth 3Y7.94%
FCF growth 5Y22.24%
OCF growth 1Y45.08%
OCF growth 3Y5.11%
OCF growth 5Y21.32%